Search Results - "Chandiwana, Precious"

SARS-CoV-2 Serological testing in frontline health workers in Zimbabwe by Rusakaniko, Simbarashe, Sibanda, Elopy Nemele, Mduluza, Takafira, Tagwireyi, Paradzayi, Dhlamini, Zephaniah, Ndhlovu, Chiratidzo Ellen, Chandiwana, Precious, Chiwambutsa, Shingirai, Lim, Rivka May, Scott, Fiona, Sibanda, Lindiwe Majele, Mutapi, Francisca

“…In order to protect health workers from SARS-CoV-2, there is need to characterise the different types of patient facing health workers. Our first aim was to…”
Get full text

The University of Zimbabwe College of Health Sciences (UZ-CHS) BIRTH COHORT study: rationale, design and methods by Duri, Kerina, Gumbo, Felicity Z, Munjoma, Privilege T, Chandiwana, Precious, Mhandire, Kudakwashe, Ziruma, Asaph, Macpherson, Andrew, Rusakaniko, Simbarashe, Gomo, Exnevia, Misselwitz, Benjamin, Mazengera, Lovemore Ronald

“…Commencing lifelong antiretroviral therapy (ART) immediately following HIV diagnosis (Option B+), has greatly improved maternal-infant health. Thus, large and…”
Get full text

Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial by Turkova, Anna, Waalewijn, Hylke, Chan, Man K, Bollen, Pauline D J, Bwakura-Dangarembizi, Mutsa F, Kekitiinwa, Adeodata R, Cotton, Mark F, Lugemwa, Abbas, Variava, Ebrahim, Ahimbisibwe, Grace Miriam, Srirompotong, Ussanee, Mumbiro, Vivian, Amuge, Pauline, Zuidewind, Peter, Ali, Shabinah, Kityo, Cissy M, Archary, Moherndran, Ferrand, Rashida A, Violari, Avy, Gibb, Diana M, Burger, David M, Ford, Deborah, Colbers, Angela

“…Children with HIV-associated tuberculosis (TB) have few antiretroviral therapy (ART) options. We aimed to evaluate the safety and pharmacokinetics of…”
Get full text

Once-daily dolutegravir-based antiretroviral therapy in infants and children living with HIV from age 4 weeks: results from the below 14 kg cohort in the randomised ODYSSEY trial by Amuge, Pauline, Lugemwa, Abbas, Wynne, Ben, Mujuru, Hilda A, Violari, Avy, Kityo, Cissy M, Archary, Moherndran, Variava, Ebrahim, White, Ellen, Turner, Rebecca M, Shakeshaft, Clare, Ali, Shabinah, Nathoo, Kusum J, Atwine, Lorna, Liberty, Afaaf, Bbuye, Dickson, Kaudha, Elizabeth, Mngqibisa, Rosie, Mosala, Modehei, Mumbiro, Vivian, Nanduudu, Annet, Ankunda, Rogers, Maseko, Lindiwe, Kekitiinwa, Adeodata R, Giaquinto, Carlo, Rojo, Pablo, Gibb, Diana M, Turkova, Anna, Ford, Deborah

“…Young children living with HIV have few treatment options. We aimed to assess the efficacy and safety of dolutegravir-based antiretroviral therapy (ART) in…”
Get full text

CCR2, CX3CR1, RANTES and SDF1 genetic polymorphisms influence HIV infection in a Zimbabwean pediatric population by Mhandire, Kudakwashe, Duri, Kerina, Kandawasvika, Gwendoline, Chandiwana, Precious, Chin'ombe, Nyasha, Kanyera, Russell Batsirai, Stray-Pedersen, Babill, Dandara, Collet

“…There is growing evidence that polymorphisms in chemokine and chemokine receptor genes influence susceptibility to HIV infection and disease progression…”
Get full text